glp 1 gip triple agonist Schematic illustration of monoagonists, dual agonists and retatrutide mechanism of action triple

2021;911 doi: 10.1016/j.ejphar.2021.174482

[1] [24] If outside these windows, skip the missed dose and resume the regular schedule

It is important to emphasize that GLP-1 therapies do not directly modify fundamental aging mechanisms

Within 8 weeks, energy improved, nausea resolved, and DEXA confirmed preservation of lean mass

GLP-1 plays a key role in the occurrence and development of metabolic diseases such as obesity, nonalcoholic fatty liver disease, and atherosclerosis by regulating lipid metabolism

Keep checking back, because we will keep updating this chart based on the lasts research findings and FDA Approvals